Appendix 3B - Issue of Employee Options | RNS | Ticker

/News/RNS

Appendix 3B - Issue of Employee Options

RNS Announcement

RNS Number : 3037F

Oilex Ltd

19 February 2015

ASX Announcement

19 February 2015

ASX: OEX

AIM: OEX

Appendix 3B - Issue of Employee Options

Dear Sirs

We enclose an Appendix 3B advising of the following issue of employee options:

· 500,000 Unlisted Options exercisable at $0.25 vesting 16 February 2015, expiring 16 February 2018;

· 500,000 Unlisted Options exercisable at $0.35 vesting 16 February 2016, expiring 16 February 2019.

For and on behalf of Oilex Ltd

Chris Bath

Chief Financial Officer and Company Secretary

For further information, please contact:

Oilex Ltd

Ron Miller, Managing Director

Email: [email protected]

Tel: +61 8 9485 3200

Australia

Strand Hanson Limited

Nominated Adviser and AIM Broker

Rory Murphy/Ritchie Balmer

Email: [email protected]

Tel: +44 20 7409 3494

Tavistock Communications

Ed Portman

Email: [email protected]

Tel: +44 20 7920 3150

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement,

application for quotation of additional securities

and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

OILEX LTD

ABN

50 078 652 632

We (the entity) give ASX the following information.

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1	+Class of +securities issued or to be issued	Unlisted Options

2	Number of +securities issued or to be issued (if known) or maximum number which may be issued	1,000,000

3	Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)	500,000 unlisted options exercisable at $0.25 vesting 16 February 2015 and expiring on 16 February 2018 500,000 unlisted options exercisable at $0.35 vesting 16 February 2016 and expiring on 16 February 2019

4	Do the ⁺securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities? If the additional securities do not rank equally, please state: · the date from which they do · the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment · the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment	Not applicable

5	Issue price or consideration	Nil

6	Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets)	Granted to an employee

6a	Is the entity an ⁺eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i	No

6b	The date the security holder resolution under rule 7.1A was passed	Not applicable

6c	Number of ⁺securities issued without security holder approval under rule 7.1	Not applicable

6d	Number of ⁺securities issued with security holder approval under rule 7.1A	Not applicable

6e	Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)	Not applicable

6f	Number of ⁺securities issued under an exception in rule 7.2	Not applicable

6g	If ⁺securities issued under rule 7.1A was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the ⁺issue date and both values. Include the source of the VWAP calculation.	Not applicable

6h	If ⁺securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements	Not applicable

6i	Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements	Not applicable

7	⁺Issue dates Notes: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in appendix 7A. Cross reference: item 33 of Appendix 3B.	16 February 2015

8	Number and +class of all +securities quoted on ASX (including the ⁺securities in section 2 if applicable)	Number		⁺Class
		677,905,419 188,597,091		Fully Paid Ordinary Shares Listed options exercisable at $0.15 each by 07/09/2015

9	Number and +class of all +securities not quoted on ASX (including the securities in section 2 if applicable)	Number	+Class
		75,000 3,000,000 5,000,000 500,000 2,000,000 2,000,000 3,000,000 250,000 500,000 1,325,000 1,500,000 2,000,000 5,000,000 500,000 250,000 1,325,000 500,000 4,000,000 1,500,000	$0.63 Options due 01/08/2015 $0.15 Options due 17/12/2015 $0.25 Options due 08/03/2016 $0.15 Options due 27/06/2016 $0.15 Options due 04/11/2016 $0.15 Options due 11/11/2016 $0.15 Options due 05/12/2016 $0.15 Options due 10/03/2017 $0.25 Options due 27/06/2017 $0.25 Options due 05/08/2017 $0.25 Options due 25/08/2017 $0.25 Options due 11/11/2017 $0.10 Options due 22/12/2017 $0.25 Options due 16/02/2018 $0.25 Options due 10/03/2018 $0.35 Options due 05/08/2018 $0.35 Options due 16/02/2019 $0.15 Options due 29/04/2019 $0.35 Options due 25/08/2019

10	Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)	Not applicable

Part 2 ‑ Pro rata issue

11	Is security holder approval required?	Not applicable

12	Is the issue renounceable or non-renounceable?

13	Ratio in which the +securities will be offered

14	+Class of +securities to which the offer relates

15	+Record date to determine entitlements

16	Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

17	Policy for deciding entitlements in relation to fractions

18	Names of countries in which the entity has security holders who will not be sent new issue documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7.

19	Closing date for receipt of acceptances or renunciations

20	Names of any underwriters

21	Amount of any underwriting fee or commission

22	Names of any brokers to the issue

23	Fee or commission payable to the broker to the issue


24			Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders

25			If the issue is contingent on security holders' approval, the date of the meeting

26			Date entitlement and acceptance form and offer documents will be sent to persons entitled

27			If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

28			Date rights trading will begin (if applicable)

29			Date rights trading will end (if applicable)

30			How do security holders sell their entitlements in full through a broker?

31			How do security holders sell part of their entitlements through a broker and accept for the balance?

32			How do security holders dispose of their entitlements (except by sale through a broker)?

33			+Issue date

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

34	Type of securities (tick one)
(a)	o	⁺Securities described in Part 1

(b)	o	All other ⁺securities Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or documents

35		If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

36		If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

37		A copy of any trust deed for the additional +securities

Entities that have ticked box 34(b)
38	Number of securities for which +quotation is sought		Not applicable

39	+Class of +securities for which quotation is sought

40	Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities? If the additional +securities do not rank equally, please state: · the date from which they do · the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment · the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

41	Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another ⁺security, clearly identify that other ⁺security)

Number and +class of all +securities quoted on ASX (including the securities in clause 38)

Number

⁺Class

Quotation agreement

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

2 We warrant the following to ASX.

· The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

· There is no reason why those +securities should not be granted +quotation.

· An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

· Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

· If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Chris Bath

(Chief Financial Officer / Company Secretary)

This information is provided by RNS

The company news service from the London Stock Exchange

END

IOEGGURUPUPAUPB

RNS metadata

Title: Appendix 3B - Issue of Employee Options
Time: 07:00:05
Date: 19 Feb 2015
Category: Capital structure
ID: 3037F

Appendix 3B

New issue announcement,

application for quotation of additional securities

and agreement

Part 1 ‑ All issues

Part 2 ‑ Pro rata issue

Part 3 ‑ Quotation of securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Entities that have ticked box 34(b)

Quotation agreement